This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: National Institute of Radiological Sciences. Active years: 2010-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2012
Title: Mayumi Iwakawa: Innovator in Cancer Prediction and Genomic DNA Amplification
Introduction
Mayumi Iwakawa is a prominent inventor based in Chiba, Japan. She has made significant contributions to the field of cancer research and genomic technology. With a total of 2 patents, her work focuses on innovative methods for predicting cancer metastasis and amplifying genomic DNA.
Latest Patents
Iwakawa's latest patents include a method for predicting the metastasis of oral cavity cancer into cervical lymph nodes. This method provides a way to objectively assess the likelihood of metastasis in early-stage cases diagnosed with oral cavity cancer. It involves assaying the expression amounts of specific metastasis prediction genes, which differ between metastasis and non-metastasis groups. The genes MSR1 and RET are key components of this predictive method.
Another significant patent is a method for amplifying genomic DNA. This method includes several steps, such as incubating a cell-containing agarose solution at a specific pH and temperature to produce a genomic DNA-dispersed agarose solution. The process further involves solidifying this solution and adding DNA polymerase, primers, and dNTP to amplify the genomic DNA effectively.
Career Highlights
Mayumi Iwakawa is affiliated with the National Institute of Radiological Sciences, where she conducts her research and development. Her work has been instrumental in advancing the understanding of cancer metastasis and improving diagnostic techniques.
Collaborations
Iwakawa collaborates with notable colleagues, including Takashi Imai and Yuichi Michikawa. Their combined expertise contributes to the innovative research being conducted at the National Institute of Radiological Sciences.
Conclusion
Mayumi Iwakawa's contributions to cancer research and genomic technology highlight her role as a leading inventor in her field. Her innovative methods for predicting cancer metastasis and amplifying genomic DNA are paving the way for advancements in medical diagnostics and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile